Linkedin
Ursula Costa
DayOne Healthcare Innovation
I want to extend my congratulations to MTIP and Stifel Europe for orchestrating an incredible gathering of decision-makers, thought leaders, and investors.
Here are some key takeaways:
1️⃣ Healthtech Investment:
After a decade of exponential growth (x10 in the last 10 years), 2023 marked a pivotal moment as healthtech seemed to hit rock bottom.
However, history shows us that even in the face of challenges, there’s room for major players to emerge, just as Amazon transformed commerce during the Dotcom bubble.
It’s time to reimagine healthcare and not just patch problems but completely rearchitect the system.
2️⃣ Healthtech is Not the Future; It’s the Present:
With one-third of radiologists already using AI, 20% of consultations conducted online, and the persistent shortage of healthcare staff coupled with an aging population, healthtech is no longer a distant vision but a current necessity.
healthtech is no longer a distant vision but a current necessity.
3️⃣ Beyond Patients and Clinicians:
Pharma is a significant consumer of healthtech, and AI applications are already making strides in drug discovery.
4️⃣ Digital Therapeutics:
Expect continued growth and diverse applications in this field, with the potential to deliver both outcomes and patient satisfaction.
5️⃣ Global Expansion with the 70/30 Rule:
To thrive in Europe and beyond, you need a ‘glocal’ approach. Around 70% of the solution can be common, but mastering the other 30% is the key to success.
Partnering with global giants like big pharma or medtech can provide a competitive edge by understanding unique market access and factors in different countries.
6️⃣ Challenges of International Expansion:
Scaling internationally comes with its set of challenges, but it’s essential for achieving scale. Expanding to markets like Asia can also offer advantages in terms of data access. Different markets have different needs, and finding the right balance between standalone and integrated solutions is crucial.
7️⃣ Investment Landscape:
Valuations are no longer doubling every two years. Startups today need a compelling value proposition, an exceptional team, and a clear path to profitability. Venture debt, an underutilized instrument in Europe, can be a game-changer.
8️⃣ DayOne’s Strong Presence:
It was an honor to witness DayOne’s remarkable representation at the event. Three alumni startups, Resmonics, Moonlight AI, and OptiChroniX, showcased their innovation, while Maya Zlatanova from FindMeCure graced the main stage. Reconnecting with many other alumni in the audience reaffirmed Basel’s status as a major Healthtech Hub.
The event was a reminder that even in challenging times, the healthtech industry holds immense potential for those willing to innovate and collaborate. I’m excited to be part of this transformative journey!
Originally published at — https://www.linkedin.com/in/ucosta/
